Literature DB >> 27076905

Determinants of 6-minute walk distance in patients with idiopathic pulmonary fibrosis undergoing lung transplant evaluation.

Mary K Porteous1, Belinda N Rivera-Lebron2, Maryl Kreider3, James Lee1, Steven M Kawut4.   

Abstract

Little is known about the physiologic determinants of 6-minute walk distance in idiopathic pulmonary fibrosis. We investigated the demographic, pulmonary function, echocardiographic, and hemodynamic determinants of 6-minute walk distance in patients with idiopathic pulmonary fibrosis evaluated for lung transplantation. We performed a cross-sectional analysis of 130 patients with idiopathic pulmonary fibrosis who completed a lung transplantation evaluation at the Hospital of the University of Pennsylvania between 2005 and 2010. Multivariable linear regression analysis was used to generate an explanatory model for 6-minute walk distance. After adjustment for age, sex, race, height, and weight, the presence of right ventricular dilation was associated with a decrease of 50.9 m (95% confidence interval [CI], 8.4-93.3) in 6-minute walk distance ([Formula: see text]). For each 200-mL reduction in forced vital capacity, the walk distance decreased by 15.0 m (95% CI, 9.0-21.1; [Formula: see text]). For every increase of 1 Wood unit in pulmonary vascular resistance, the walk distance decreased by 17.3 m (95% CI, 5.1-29.5; [Formula: see text]). Six-minute walk distance in idiopathic pulmonary fibrosis depends in part on circulatory impairment and the degree of restrictive lung disease. Future trials that target right ventricular morphology, pulmonary vascular resistance, and forced vital capacity may potentially improve exercise capacity in patients with idiopathic pulmonary fibrosis.

Entities:  

Keywords:  exercise capacity; interstitial lung disease; right ventricular dilation

Year:  2016        PMID: 27076905      PMCID: PMC4809664          DOI: 10.1086/685022

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  40 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.

Authors:  Herre J Reesink; Mart N van der Plas; Niesje E Verhey; Reindert P van Steenwijk; Jaap J Kloek; Paul Bresser
Journal:  J Thorac Cardiovasc Surg       Date:  2007-02       Impact factor: 5.209

3.  The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis.

Authors:  Christopher J Lettieri; Steven D Nathan; Robert F Browning; Scott D Barnett; Shahzad Ahmad; Andrew F Shorr
Journal:  Respir Med       Date:  2006-03-20       Impact factor: 3.415

4.  Right ventricular dilatation during exercise. A new sign?

Authors:  Carlos Cotrim; M J Loureiro; Rita Miranda; Corina Lohmann; Otília Simões; Pedro Cordeiro; Renato Fernandes; Sofia Almeida; Luís Lopes; Manuel Carrageta
Journal:  Rev Port Cardiol       Date:  2007-09       Impact factor: 1.374

5.  6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis.

Authors:  Roland M du Bois; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Jonathan A Leff; Paul W Noble; Steven A Sahn; Dominique Valeyre; Derek Weycker; Talmadge E King
Journal:  Eur Respir J       Date:  2013-12-05       Impact factor: 16.671

6.  Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis.

Authors:  Sven Gläser; Oliver Noga; Beate Koch; Christian F Opitz; Bernd Schmidt; Bettina Temmesfeld; Marcus Dörr; Ralf Ewert; Christoph Schäper
Journal:  Respir Med       Date:  2008-09-18       Impact factor: 3.415

7.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

Review 8.  Clinical course and prediction of survival in idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Harold R Collard; Talmadge E King
Journal:  Am J Respir Crit Care Med       Date:  2010-10-08       Impact factor: 21.405

9.  Functional predictors of exertional dyspnea, 6-min walking distance and HRCT fibrosis score in idiopathic pulmonary fibrosis.

Authors:  Marco Mura; Anna Ferretti; Orazio Ferro; Maurizio Zompatori; Alberto Cavalli; Mario Schiavina; Mario Fabbri
Journal:  Respiration       Date:  2005-11-07       Impact factor: 3.580

10.  Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.

Authors:  Margaret C Garin; Kristin B Highland; Richard M Silver; Charlie Strange
Journal:  J Rheumatol       Date:  2009-01-22       Impact factor: 4.666

View more
  2 in total

1.  Relationship between body composition, exercise capacity and health-related quality of life in idiopathic pulmonary fibrosis.

Authors:  Felipe V C Machado; Ada E M Bloem; Tessa Schneeberger; Inga Jarosch; Rainer Gloeckl; Sandra Winterkamp; Frits M E Franssen; Andreas R Koczulla; Fabio Pitta; Martijn A Spruit; Klaus Kenn
Journal:  BMJ Open Respir Res       Date:  2021-10

2.  Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.

Authors:  Panaiotis Finamore; Claudio Pedone; Simone Scarlata; Alessandra Di Paolo; Simone Grasso; Marco Santonico; Giorgio Pennazza; Raffaele Antonelli Incalzi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-05-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.